Signe Rosenlund

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

Ofri Mosenzon, Thalia Marie Blicher, Signe Rosenlund et al. · The Lancet Diabetes & Endocrinology · 2019 · 317 citations · Full text

Diabetes Management, Urology, Medicine +11

Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

Nete Tofte, Morten Lindhardt, Katarina Adamova et al. · The Lancet Diabetes & Endocrinology · 2020 · 247 citations · Full text

Urology, Renal Disease, Renal Function +8

The effect of liraglutide on renal function: A randomized clinical trial

Bernt Johan von Scholten, Frederik Persson, Signe Rosenlund et al. · Diabetes Obesity and Metabolism · 2016 · 99 citations

Improved Time in Range Over 1 Year Is Associated With Reduced Albuminuria in Individuals With Sensor-Augmented Insulin Pump–Treated Type 1 Diabetes

Ajenthen G. Ranjan, Signe Rosenlund, Tine W. Hansen et al. · Diabetes Care · 2020 · 70 citations · Full text

Patient-reported outcome after total hip arthroplasty: comparison between lateral and posterior approach

Signe Rosenlund, Leif Broeng, Anders Holsgaard‐Larsen et al. · Acta Orthopaedica · 2017 · 64 citations · Full text

Physical Activity, Non-operative Management, Surgery +18